<?xml version="1.0" encoding="UTF-8" ?><!-- generator=Zoho Sites --><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><atom:link href="https://www.spiroscoutusa.com/blogs/spirometry/feed" rel="self" type="application/rss+xml"/><title>Spiroscout - Blog , Spirometry</title><description>Spiroscout - Blog , Spirometry</description><link>https://www.spiroscoutusa.com/blogs/spirometry</link><lastBuildDate>Wed, 25 Feb 2026 08:31:03 -0800</lastBuildDate><generator>http://zoho.com/sites/</generator><item><title><![CDATA[Pulmonologist burnout: statistics and suggestions to cope ]]></title><link>https://www.spiroscoutusa.com/blogs/post/Pulmonologist-burnout</link><description><![CDATA[<img align="left" hspace="5" src="https://www.spiroscoutusa.com/bornout.jpg"/>Burnout is a problem that affects many people. And the COVID-19 pandemic greatly increased it among pulmonologists and other respiratory specialists who provide critical care.]]></description><content:encoded><![CDATA[<div class="zpcontent-container blogpost-container "><div data-element-id="elm_qABtLLrqStCJMEpRteHByQ" data-element-type="section" class="zpsection "><style type="text/css"></style><div class="zpcontainer-fluid zpcontainer"><div data-element-id="elm_mOA7cLsPROiJmvgUtUgzFQ" data-element-type="row" class="zprow zprow-container zpalign-items- zpjustify-content- " data-equal-column=""><style type="text/css"></style><div data-element-id="elm_PQAB4tRxSIqOVuqtEZRspA" data-element-type="column" class="zpelem-col zpcol-12 zpcol-md-12 zpcol-sm-12 zpalign-self- "><style type="text/css"> [data-element-id="elm_PQAB4tRxSIqOVuqtEZRspA"].zpelem-col{ border-radius:1px; } </style><div data-element-id="elm_WsK6YBgRR0CBk1x8auIvyw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_WsK6YBgRR0CBk1x8auIvyw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-center " data-editor="true"><div style="color:inherit;"><p style="text-align:left;">Burnout is a problem that affects many people. And the COVID-19 pandemic greatly increased it among pulmonologists and other respiratory specialists who provide critical care.<span style="color:inherit;text-align:center;">&nbsp;</span></p><p style="text-align:left;">To the overload work caring for coronavirus patients we need to add the limited resources, the longer work shifts, the lack of sleep, the imbalance between personal and professional life, and, of course, the stress involved in being constantly exposed to the disease. How do all these factors affect pulmonologists?</p></div></div>
</div><div data-element-id="elm_wQEYa1mmpAJasmCzWxWDMg" data-element-type="image" class="zpelement zpelem-image "><style> @media (min-width: 992px) { [data-element-id="elm_wQEYa1mmpAJasmCzWxWDMg"] .zpimage-container figure img { width: 500px ; height: 346.15px ; } } @media (max-width: 991px) and (min-width: 768px) { [data-element-id="elm_wQEYa1mmpAJasmCzWxWDMg"] .zpimage-container figure img { width:500px ; height:346.15px ; } } @media (max-width: 767px) { [data-element-id="elm_wQEYa1mmpAJasmCzWxWDMg"] .zpimage-container figure img { width:500px ; height:346.15px ; } } [data-element-id="elm_wQEYa1mmpAJasmCzWxWDMg"].zpelem-image { border-radius:1px; } </style><div data-caption-color="" data-size-tablet="" data-size-mobile="" data-align="center" data-tablet-image-separate="false" data-mobile-image-separate="false" class="zpimage-container zpimage-align-center zpimage-size-medium zpimage-tablet-fallback-medium zpimage-mobile-fallback-medium hb-lightbox " data-lightbox-options="
                type:fullscreen,
                theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/bornout.jpg" width="500" height="346.15" loading="lazy" size="medium" data-lightbox="true"/></picture></span></figure></div>
</div><div data-element-id="elm_f9QHEyOtXKHTJVkcrUjJmQ" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_f9QHEyOtXKHTJVkcrUjJmQ"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p>The portrait in figures</p></div></h2></div>
<div data-element-id="elm_Nvs_hlPZDt1TIYCLibiprg" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_Nvs_hlPZDt1TIYCLibiprg"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>The document “Changes in Burnout and Satisfaction With Work-Life Integration in Physicians and the General US Working Population Between 2011 and 2020” published by the Mayo Clinic, and work-life integration satisfaction among physicians and other non-health professionals.&nbsp; </p><p>&nbsp;</p><p>This study involved 7510 physicians. Of thosespecialties related to COVID-19, 38.2% reported having suffered more than one burnout symptom in 2020. Overall, compared to other professionals, the risk of burnout among physicians was OR, 1.41; 95% CI, 1.25 to 1.58 and their degree of satisfaction with work-life balance was OR, 0.71; 95% CI, 0.64 to 0.79.</p><p>&nbsp;</p><p>And what is the situation among pulmonologists? According to the data provided by the report of the survey carried out in 2021 by Medscape, this is how the participating doctors who practice this specialty feel:<span style="color:inherit;">&nbsp;</span></p><ul><li>61% of the 12,339 respondents were male.&nbsp;</li><li><span style="color:inherit;">82% felt happier outside of work before the pandemic.</span></li><li><span style="color:inherit;">47% feel happier outside of work currently.</span><br></li><li><span style="color:inherit;">32% experienced burnout or depression.</span><br></li><li><span style="color:inherit;">37% consider that burnout impacts them strongly.</span><br></li><li><span style="color:inherit;">Some of the mentioned factors that contribute most to pulmonologists burnout were:</span></li></ul><ol><li>58% perform too many bureaucratic tasks.</li><li>39 % Insufficient compensation/or reimbursement.</li><li>38% spend a lot of time at work</li></ol><p>&nbsp;</p><ul><li>Surprisingly, pulmonologists are not looking to make more money (only 13% acknowledged that this would make them feel better) but their focus is on finding the balance between personal and professional life (52%).&nbsp;</li><li><span style="color:inherit;">However, their answers to the question that if they would accept a salary reduction in order to achieve such a balance slightly contradicts the above: 51% answered no. And despite the lack of time for their personal life, 63% consider they have a happy marriage.</span><br></li></ul><p>&nbsp;<span style="color:inherit;">You will have already noticed that the solution to most burnout risks is reaching balance, but how to find it?</span></p><p>&nbsp;</p></div></div>
</div><div data-element-id="elm_jgBUjZkBVgCokGXzJ4Yl-w" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_jgBUjZkBVgCokGXzJ4Yl-w"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p>Strategies to cope with burnout</p></div></h2></div>
<div data-element-id="elm_FlTQsSt572nA_WeU7yGd4A" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_FlTQsSt572nA_WeU7yGd4A"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>Since external factors are so difficult to control, it is necessary to find a way to govern what happens inside. Thus, it is advisable strategy and stick to it; it seems like a simple solution, but tell me: are you clear about yours? I don't mean isolated ideas, but a set of guidelines so coherent that you could even stop reading this for a moment to put them in writing, in whatever you have at hand.</p><p>&nbsp;</p><p>To defeat burnout, I will not suggest what you already know: eat healthy, exercise often or seek professional therapeutic help; those are effective measures, but most people fail to carry them out as they would like to. Do you know why? Because they don't have a map. To get to a place you need a map that show the destination, the road to follow and the intermediate stops. Make your own! </p><p>&nbsp;</p><p>And preferably put it in writing; not to remember what needs to be done, but so that you can assess whether you have reached your goals to balance your life. When these are not materialized in words, it is easy to feel that one does not advance, but after a while, review them and you will be surprised to notice what you have achieved. </p><p>&nbsp;</p><p>In addition, for this to be practical it must be flexible. Make all the required adjustments until you find the right dose of habits and practices that give you the greatest therapeutic effects to combat burnout. </p><p>&nbsp;</p><p>One more thing to keep burnout under control: take advantage of technology to make your daily work easier and faster. The SpiroScout is an ultrasonic spirometer that allows to perform fast, accurate, reliable tests, and it generates reports that are easy to interpret and graphical trends to easy follow, Besides you can claim the following CPT codes*:</p><p><b style="color:inherit;">Code 94010. $36.00. </b><span style="color:inherit;">Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation.**</span></p><p><b>Code 94060. $62.00. </b>Bronchodilation responsiveness, pre-and post-bronchodilator administration.</p><p><b>Code 94150. $26.00</b>. Vital capacity, total (separate procedure).</p><p><b>Code 94200. $26.00</b>. Maximum breathing capacity, maximal voluntary ventilation.</p><p><b>Code 94375. $40.00. </b>Respiratory flow volume loop.<b></b></p><p>&nbsp;</p><p><span style="font-size:12pt;color:inherit;">&nbsp;</span><a href="https://www.spiroscoutusa.com/#cpt-codes" style="font-size:12pt;">Click here</a>&nbsp;to find out how to take advantage of this ally in your daily practice.<span style="color:inherit;">&nbsp;</span></p><p>*CPT codes and reimbursements are provided as an example only and constitute no promise by Schiller or its subsidiaries regarding coverage or payment.</p><p>** CPT Code 94010 is the most commonly used in the market.</p><p>&nbsp;</p><p>&nbsp;<span style="color:inherit;">REFERENCES</span></p><p>Changes in Burnout and Satisfaction With Work-Life Integration in Physicians and the General US Working Population Between 2011 and 2020 <a href="https://www.mayoclinicproceedings.org/article/S0025-6196%2821%2900872-7/fulltext">https://www.mayoclinicproceedings.org/article/S0025-6196(21)00872-7/fulltext</a><span style="color:inherit;">&nbsp;</span></p><p>Medscape Pulmonologist Lifestyle, Happiness &amp; Burnout Report 2021 <a href="https://www.medscape.com/slideshow/2021-lifestyle-pulmonologist-6013523#8">https://www.medscape.com/slideshow/2021-lifestyle-pulmonologist-6013523#8</a></p></div></div>
</div></div></div></div></div></div> ]]></content:encoded><pubDate>Thu, 31 Mar 2022 15:43:51 +0000</pubDate></item><item><title><![CDATA[Pulmonary arterial hypertension: patient stratification and therapeutic advances]]></title><link>https://www.spiroscoutusa.com/blogs/post/Pulmonary-arterial-hypertension</link><description><![CDATA[<img align="left" hspace="5" src="https://www.spiroscoutusa.com/pulmonary3.jpg"/>Pulmonary arterial hypertension: patient stratification and therapeutic advances. is a global problem with elevated morbidity and mortality]]></description><content:encoded><![CDATA[<div class="zpcontent-container blogpost-container "><div data-element-id="elm_rRgjZWnyReKtK4HyxTrh1w" data-element-type="section" class="zpsection "><style type="text/css"></style><div class="zpcontainer-fluid zpcontainer"><div data-element-id="elm_rTuLO5FgQUeEOjxkLDWxXQ" data-element-type="row" class="zprow zprow-container zpalign-items- zpjustify-content- " data-equal-column=""><style type="text/css"></style><div data-element-id="elm_WjWXLi2iTRWqh_xfl3IUSg" data-element-type="column" class="zpelem-col zpcol-12 zpcol-md-12 zpcol-sm-12 zpalign-self- zpsticky-enabled"><style type="text/css"> [data-element-id="elm_WjWXLi2iTRWqh_xfl3IUSg"].zpelem-col{ border-radius:1px; } @media (min-width:992px) { [data-element-id="elm_WjWXLi2iTRWqh_xfl3IUSg"].zpelem-col{ top:0px;z-index:1; } } </style><div data-element-id="elm_ychkC9TdSQqSOqgLteeGwA" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_ychkC9TdSQqSOqgLteeGwA"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-center " data-editor="true"><div style="color:inherit;"><p style="text-align:left;">Pulmonary arterial hypertension (PAH) is a global problem with elevated morbidity and mortality because it complicates many diseases related to the cardiopulmonary system. And this risk is even higher due to the high prevalence of congenital heart disease: there are an estimated 25 cases of pulmonary arterial hypertension related to congenital heart disease per million inhabitants worldwide.</p></div></div>
</div><div data-element-id="elm_3uRHnz6bv0JpCmSrCsyPIA" data-element-type="image" class="zpelement zpelem-image "><style> @media (min-width: 992px) { [data-element-id="elm_3uRHnz6bv0JpCmSrCsyPIA"] .zpimage-container figure img { width: 650px !important ; height: 450px !important ; } } @media (max-width: 991px) and (min-width: 768px) { [data-element-id="elm_3uRHnz6bv0JpCmSrCsyPIA"] .zpimage-container figure img { width:650px ; height:450px ; } } @media (max-width: 767px) { [data-element-id="elm_3uRHnz6bv0JpCmSrCsyPIA"] .zpimage-container figure img { width:650px ; height:450px ; } } [data-element-id="elm_3uRHnz6bv0JpCmSrCsyPIA"].zpelem-image { border-radius:1px; } </style><div data-caption-color="" data-size-tablet="" data-size-mobile="" data-align="center" data-tablet-image-separate="false" data-mobile-image-separate="false" class="zpimage-container zpimage-align-center zpimage-size-original zpimage-tablet-fallback-original zpimage-mobile-fallback-original hb-lightbox " data-lightbox-options="
                type:fullscreen,
                theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/pulmonary3.jpg" width="650" height="450" loading="lazy" size="original" data-lightbox="true"/></picture></span></figure></div>
</div><div data-element-id="elm_tpfAxU6lzLN66iPyvPjkDQ" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_tpfAxU6lzLN66iPyvPjkDQ"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>PAH can occur due to heart disease, as we already said, but it can also occur due to clots or other chronic diseases. The remodeling of the pulmonary vasculature and the progressive increase of the pulmonary vascular load that are characteristic of this syndrome, generate hypertrophy and remodeling of the right ventricle that, without treatment, are fatal.&nbsp;</p></div></div>
</div><div data-element-id="elm_KEDsTWoS9KknVWvKZhXUmw" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_KEDsTWoS9KknVWvKZhXUmw"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p>Stratifying patients</p></div></h2></div>
<div data-element-id="elm_fZlS8yEy4n7uAp4NN8sopw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_fZlS8yEy4n7uAp4NN8sopw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>The 2015 Guidelines s for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology – European Respiratory Society (ESC/ERS, respectively) indicate that it is a priority to stratify patients effectively and promptly in order to choose the most appropriate therapy for each case.&nbsp; </p><p>&nbsp;</p><p>On the other hand, there are currently five clinical classifications (or groups) of pulmonary arterial hypertension:</p><p>&nbsp;</p><p><b>1 Pulmonary Arterial Hypertension (PAH). </b>The cause is the reduction or stiffness of the pulmonary arteries, which forces the right side of the heart to work harder.</p><p>&nbsp;<b style="color:inherit;">2 Pulmonary hypertension due to left heart disease. </b><span style="color:inherit;">The cause may be a problem with a valve (mitral or aortic) on the left side of the heart or a failure of the left ventricle.</span></p><p><b>&nbsp;</b><b style="color:inherit;">3 Pulmonary hypertension due to lung disease.&nbsp; </b><span style="color:inherit;">When the patient has a lung disease (e.g. COPD) or some other disease that causes hypoxia.</span></p><p><b>&nbsp;</b><b style="color:inherit;">4 Pulmonary hypertension caused by chronic clots. </b><span style="color:inherit;">The common treatment is surgery or medications that help dissolve clots.</span><span style="color:inherit;">&nbsp;</span></p><p><b>5 Cryptogenic pulmonary hypertension. </b>&nbsp;Which is when the physician cannot determine the origin of the problem. Among the conditions that are usually associated with this type of hypertension we can mention kidney disease, metabolic disorders, inflammatory disorders or blood disorders, among others.</p><p>&nbsp;</p><p>Although the predictive capacity provided by stratification methods has improved over time using machine learning algorithms, the aforementioned ESC/ERS 2015 Guidelines suggest evaluating the risk of patients periodically since there is no a unique variable that offers enough diagnostic and prognosis information.<span style="color:inherit;">&nbsp;</span></p><p>That is why it is necessary the physician establishes a multidimensional treatment strategy that includes various tests such as echocardiography, CT scans, spirometry and pulmonary function tests, among other useful tools.</p></div></div>
</div><div data-element-id="elm_WfKLR1rHgwHSdZmECLlj-w" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_WfKLR1rHgwHSdZmECLlj-w"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p>Sotatercept, a hope?</p></div></h2></div>
<div data-element-id="elm_hMajtxGDWeXIefSX7lbyPw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_hMajtxGDWeXIefSX7lbyPw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>To the already known treatments, for example, diuretics to promote euvolemia or anticoagulant therapy (now only indicated for idiopathic PAH), one more option is added.<span style="color:inherit;">&nbsp;</span></p><p>It is a PULSAR trial (published in April 2021) in which the efficacy of sotatercept, a new fusion protein composed of the extracellular domain of the human activin receptor type IIA fused with the Fc domain of human igG1, was tested. In other words, this compound binds the activines and the growth differentiation factors to try to restore the balance in the growth promoting signals and the growth inhibitors.<span style="color:inherit;">&nbsp;</span></p><p>The trial lasted 24 weeks in which 106 adults receiving baseline therapy for pulmonary arterial hypertension were randomly selected. They were given subcutaneous sotatercept at a dose of 0.3 mg per kilogram of body weight every 3 weeks or 0.7 mg per kilogram every 3 weeks or a placebo. The primary endpoint was the change in pulmonary vascular resistance from trial initiation to week 24.<span style="color:inherit;">&nbsp;</span></p><p>This trial demonstrated that sotatercept reduces pulmonary vascular resistance in patients receiving background monotherapy, double therapy, or triple therapy, including those receiving prostacyclin infusion therapy. Decreased pulmonary vascular resistance in the sotatercept groups was achieved by reducing mean pulmonary arterial pressure, without causing a substantial change in cardiac output or pulmonary artery wedge pressure. </p><p>&nbsp;<span style="color:inherit;">Preclinical evidence suggests that sotatercept has a direct effect on pulmonary vascular remodeling, which may explain its clinical effect on pulmonary artery pressure.&nbsp; Although there is still a long way to go, these initial results are good news for PAH patients.</span></p><div style="color:inherit;"><p>REFERENCIAS Pulmonary Arterial Hypertension: <a href="https://www.nejm.org/doi/full/10.1056/NEJMra2000348">https://www.nejm.org/doi/full/10.1056/NEJMra2000348</a>,<br><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2024277">Sotatercept for the Treatment of Pulmonary Arterial Hypertension</a>, <br><a href="https://www.revespcardiol.org/index.php?p=revista&tipo=pdf-simple&pii=S1885585716000244">2015 Guidelines s for the Diagnosis and Treatment of Pulmonary Hypertension</a></p></div>
<span style="font-size:12pt;"><br></span></div></div></div></div></div></div></div>
</div> ]]></content:encoded><pubDate>Mon, 28 Mar 2022 14:43:23 +0000</pubDate></item><item><title><![CDATA[Accelerated lung function decline and menopause]]></title><link>https://www.spiroscoutusa.com/blogs/post/Accelerated-lung-function-decline-and-menopause</link><description><![CDATA[<img align="left" hspace="5" src="https://www.spiroscoutusa.com/1medical2.jpg"/>Although the role that sex hormones play in respiratory health is well known, the relationship between hormonal changes due to menopause and female lung function is a topic that deserves more attention.]]></description><content:encoded><![CDATA[<div class="zpcontent-container blogpost-container "><div data-element-id="elm_5Ql6U8A8RcembsbmWpCeMQ" data-element-type="section" class="zpsection "><style type="text/css"></style><div class="zpcontainer-fluid zpcontainer"><div data-element-id="elm_RDj81CW1SvOEUPXHIrCRfA" data-element-type="row" class="zprow zprow-container zpalign-items- zpjustify-content- " data-equal-column=""><style type="text/css"></style><div data-element-id="elm_6aJo3z-dRlGV6_2yYb7CHw" data-element-type="column" class="zpelem-col zpcol-12 zpcol-md-12 zpcol-sm-12 zpalign-self- zpsticky-enabled"><style type="text/css"> [data-element-id="elm_6aJo3z-dRlGV6_2yYb7CHw"].zpelem-col{ border-radius:1px; } @media (min-width:992px) { [data-element-id="elm_6aJo3z-dRlGV6_2yYb7CHw"].zpelem-col{ top:0px;z-index:1; } } </style><div data-element-id="elm_TV4SejF8TWans7e-GNVD9Q" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_TV4SejF8TWans7e-GNVD9Q"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-center " data-editor="true"><div style="color:inherit;"><p style="text-align:left;">Although the role that sex hormones play in respiratory health is well known, the relationship between hormonal changes due to menopause and female lung function is a topic that deserves more attention.</p></div></div>
</div><div data-element-id="elm_CjN7TlBMOonarZ2BxyysKw" data-element-type="image" class="zpelement zpelem-image "><style> @media (min-width: 992px) { [data-element-id="elm_CjN7TlBMOonarZ2BxyysKw"] .zpimage-container figure img { width: 500px ; height: 346.15px ; } } @media (max-width: 991px) and (min-width: 768px) { [data-element-id="elm_CjN7TlBMOonarZ2BxyysKw"] .zpimage-container figure img { width:500px ; height:346.15px ; } } @media (max-width: 767px) { [data-element-id="elm_CjN7TlBMOonarZ2BxyysKw"] .zpimage-container figure img { width:500px ; height:346.15px ; } } [data-element-id="elm_CjN7TlBMOonarZ2BxyysKw"].zpelem-image { border-radius:1px; } </style><div data-caption-color="" data-size-tablet="" data-size-mobile="" data-align="center" data-tablet-image-separate="false" data-mobile-image-separate="false" class="zpimage-container zpimage-align-center zpimage-size-medium zpimage-tablet-fallback-medium zpimage-mobile-fallback-medium hb-lightbox " data-lightbox-options="
                type:fullscreen,
                theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/1medical2.jpg" width="500" height="346.15" loading="lazy" size="medium" data-lightbox="true"/></picture></span></figure></div>
</div><div data-element-id="elm_kqkth9qkA3y1oVUV5_nupw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_kqkth9qkA3y1oVUV5_nupw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><p style="text-align:center;"><a href="https://www.freepik.com/premium-photo/medical-specialist-listening-retired-female-breathing_22275289.htm" title="by:&nbsp;yakobchuk/freepik" rel="">by:&nbsp;</a><a href="https://www.freepik.com/premium-photo/medical-specialist-listening-retired-female-breathing_22275289.htm" title="by:&nbsp;yakobchuk/freepik" rel="">yakobchuk</a><a href="https://www.freepik.com/premium-photo/medical-specialist-listening-retired-female-breathing_22275289.htm" title="by:&nbsp;yakobchuk/freepik" rel="">/freepik</a></p></div>
</div><div data-element-id="elm_ajUZVzh9nAmDXLEKSi5klA" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_ajUZVzh9nAmDXLEKSi5klA"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>Menopause not only marks the end of women's reproductive cycle, it also represents the beginning of great changes in their organism. It is related to important changes in the activity of 7β and low levels of this substance favor not only systemic inflammation, but also that of the lungs. </p><p>&nbsp;<span style="color:inherit;">Markers of inflammation C-reactive protein (which belongs to the family of acute phase reactants) and interleukin 6 (IL6) inversely affect </span><a href="https://www.schillerus.com/blogs/post/when-are-fev1-and-fvc-maneuvers-acceptable">FVC and FEV1</a><span style="color:inherit;">. This is what suggests a possible association between menopause and decline in lung function.</span><span style="color:inherit;">&nbsp;</span></p><p>This relationship has not yet been sufficiently studied, so the contributions of the study named <a href="https://www.atsjournals.org/doi/10.1164/rccm.201605-0968OC">&quot;Menopause Is Associated with Accelerated Lung Function Decline&quot;</a>, by &nbsp;Kai Triebner et al., propose a starting point to dive deeper into this topic. Here are the highlights of the document.</p></div></div>
</div><div data-element-id="elm_xv7AleqGSz1BGPaFTesOEg" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_xv7AleqGSz1BGPaFTesOEg"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p>Lung function and menopause</p></div></h2></div>
<div data-element-id="elm_iD26eJO3aTqzwBYJZ82WRg" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_iD26eJO3aTqzwBYJZ82WRg"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>The goal of Kai Triebner et al. was to evaluate lung function by FVC and FEV1 to see if the decline in those measurements was accelerated in menopausal women.<span style="color:inherit;">&nbsp;</span></p><p><b>Method. </b>To carry out the study, The European Community Respiratory Health Survey information about their respiratory and reproductive health.</p><p>&nbsp;<span style="color:inherit;">The researchers measured follicle stimulating (FSH) and luteinizing hormones (LH)</span></p><p>and added information from menstrual patterns to determine menopause using latent class-type analyses.<span style="color:inherit;">&nbsp;</span></p><p>To determine whether this was associated with the decline of lung function, linear mixed-effect models were used, in which the variables of age, height, weight, number of packages that the participants smoked in a certain period of years, if they were current smokers, age, and level of full-time education were adjusted. Likewise, the values obtained in the spirometry as well as the type of spirometer used in each wave of the study, were considered.</p><p>&nbsp;<b style="color:inherit;">Main outcomes. </b><span style="color:inherit;">&nbsp;Tests showed that menopause was associated with an accelerated lung function decline. In post-menopausal women, the adjusted mean FVC increased by -12.5 ml/yr (95% CI, -16.2 to -8.9) compared to those who were still menstruating. The adjusted mean FEV1 decline increased by -3.8 ml/yr (95% CI, -6.3 to -2.9) in transitional women and -5.2 ml/yr (95% CI, -8.3 to -2.0) for post-menopausal women.</span></p></div></div>
</div><div data-element-id="elm_WXOLHnq-I6A7PKwa8ERneA" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_WXOLHnq-I6A7PKwa8ERneA"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p>Conclusions</p></div></h2></div>
<div data-element-id="elm_BnSD_DFet8eTUVPDl3BGkw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_BnSD_DFet8eTUVPDl3BGkw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>This study showed that lung function declined faster in women who were in the middle of menopause and in post-menopausal women, beyond the expected decline with age. The results were consistent across subgroups and had nothing to do with smoking history. The decline of pulmonary function was more pronounced in the FVC measurements. The effect size for FEV1 measurements was comparable to smoking 20 cigarettes a day for 2 years, and FVC measurements was comparable to smoking 20 cigarettes a day for 10 years.<span style="color:inherit;">&nbsp;</span></p><p>The researchers in charge of this study concluded that the relationship between reproductive age and respiratory health needs to be investigated further. They also noted that there was also a need to investigate whether hormone replacement therapy could bring benefits to patients' lung health.</p></div></div>
</div></div></div></div></div></div> ]]></content:encoded><pubDate>Mon, 24 Jan 2022 14:58:55 +0000</pubDate></item><item><title><![CDATA[The efforts to combat COPD are never-ending]]></title><link>https://www.spiroscoutusa.com/blogs/post/The-efforts-to-combat-COPD</link><description><![CDATA[<img align="left" hspace="5" src="https://www.spiroscoutusa.com/COPD.png"/>Chronic Obstructive Pulmonary Disease (COPD) is a syndrome &nbsp;that affects the lungs, making it hard to breathe; it includes two main findings—emph ]]></description><content:encoded><![CDATA[<div class="zpcontent-container blogpost-container "><div data-element-id="elm_Z1HM01YhTwecfzggQf4JOQ" data-element-type="section" class="zpsection "><style type="text/css"></style><div class="zpcontainer-fluid zpcontainer"><div data-element-id="elm_vNd5D0uPR-yrDRbny8upgQ" data-element-type="row" class="zprow zprow-container zpalign-items- zpjustify-content- " data-equal-column=""><style type="text/css"></style><div data-element-id="elm_PhZf1ZXoSTKRmd-CVkBgqw" data-element-type="column" class="zpelem-col zpcol-12 zpcol-md-12 zpcol-sm-12 zpalign-self- "><style type="text/css"></style><div data-element-id="elm_mKfy0E6uRKmx219UXMUong" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_mKfy0E6uRKmx219UXMUong"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><p><span style="color:inherit;"><span style="font-size:12pt;">Chronic Obstructive Pulmonary Disease (COPD) is a syndrome &nbsp;that affects the lungs, making it hard to breathe; it includes two main findings—emphysema and chronic bronchitis. This problem is so severe and common that affects millions of Americans; in fact, it is the 4th leading cause of death and the third most common cause of disability</span></span><br></p></div></div></div></div></div></div></div>
</div><div data-element-id="elm_07BMwz2wgoxQ_lbtrSS0Sg" data-element-type="image" class="zpelement zpelem-image "><style> @media (min-width: 992px) { [data-element-id="elm_07BMwz2wgoxQ_lbtrSS0Sg"] .zpimage-container figure img { width: 500px ; height: 346.15px ; } } @media (max-width: 991px) and (min-width: 768px) { [data-element-id="elm_07BMwz2wgoxQ_lbtrSS0Sg"] .zpimage-container figure img { width:500px ; height:346.15px ; } } @media (max-width: 767px) { [data-element-id="elm_07BMwz2wgoxQ_lbtrSS0Sg"] .zpimage-container figure img { width:500px ; height:346.15px ; } } [data-element-id="elm_07BMwz2wgoxQ_lbtrSS0Sg"].zpelem-image { border-radius:1px; } </style><div data-caption-color="" data-size-tablet="size-original" data-size-mobile="size-original" data-align="center" data-tablet-image-separate="" data-mobile-image-separate="" class="zpimage-container zpimage-align-center zpimage-size-medium zpimage-tablet-fallback-medium zpimage-mobile-fallback-medium hb-lightbox " data-lightbox-options="
                type:fullscreen,
                theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/COPD-1.png" width="500" height="346.15" loading="lazy" size="medium" data-lightbox="true" style="width:650px !important;"/></picture></span></figure></div>
</div><div data-element-id="elm_2vvyZSrHwO-4O-dF3H5-0w" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_2vvyZSrHwO-4O-dF3H5-0w"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><p>Fortunately,&nbsp;<span style="font-size:12pt;color:inherit;">some &nbsp;forms of</span><span style="color:inherit;">&nbsp; COPD are preventable and/or treatable, thus, there are many important health organizations, like <a href="https://www.nhlbi.nih.gov/health-topics/copd" title="the National Heart, Lung and Blood Institute " target="_blank" rel="nofollow">t</a><a href="https://www.nhlbi.nih.gov/health-topics/copd" title="the National Heart, Lung and Blood Institute " target="_blank" rel="nofollow">he </a></span><a href="https://www.nhlbi.nih.gov/health-topics/copd" title="the National Heart, Lung and Blood Institute " target="_blank" rel="nofollow">National Heart, Lung and Blood Institute</a><span style="color:inherit;"> or the </span><a href="https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd">American Lung Association</a><span style="color:inherit;">, that drive their efforts to educate patients to avoid or living with this condition, and also, invest in research.</span></p><div style="color:inherit;"><p>November is COPD Awareness Month, and it is worth to check some of the advances that those organizations are making about this disease.</p></div></div></div></div></div></div></div></div></div>
</div><div data-element-id="elm_Jb9dnhuKGC08nxMgdJnBHA" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_Jb9dnhuKGC08nxMgdJnBHA"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><p>COPD research to improve lives</p></div></div></h2></div>
<div data-element-id="elm_zYV47vA-7KnxYoHOV3Kviw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_zYV47vA-7KnxYoHOV3Kviw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><p>Since 1915, The American Lung Association has supported research that has been valuable to understand the body´s immune system to offer better treatments and management. Among their contributions we can mention:</p><p><b>&nbsp;</b></p><p><b>Surfactant in babies´ lungs (1959).</b> Dr. Mary Ellen Avery, an AML grantee, discovered that the lungs of babies with respiratory distress syndrome (RDS) lack the surfactant, a mixture of phospholipids and four surfactant proteins: hydrophilic SP-A and SP-D (collectins), and the lipophilic SP-B and SP-C. Lung surfactant are the responsible of lowering the surface tension to prevent the alveolar collapse during exhalation. </p><p>&nbsp;</p><p><b>The gene that causes cystic fibrosis (1989).</b> Dr. Michael Iannuzzi´s work help to discover that a defective gene was responsible of causing the body to produce abnormally thick mucus that clogs the lungs and makes the patient prone to dangerous infections. </p><p><b>&nbsp;</b></p><p><b>The main gene of lung cancer (2008).</b> Dr. Alan Fields identified a gene that may cause lung cancer. Besides. Dr. Fields discovered that the tumor growth in lung cancer could be inhibited using a combination therapy of auranofin (a drug approved to treat arthritis) and an experimental targeted agent.</p><p>&nbsp;</p><p>The American Lung Association (ALA) founded the Airways Clinical Research Centers (ACRC) in 1999 to provide valuable information to help patients with asthma and COPD. &nbsp;Their aim is finding new ways to treat people with COPD asthma. Let´s mention a couple of those trials:</p><p>&nbsp;</p><p><b>TRIM (Trial of Roflumilast in Asthma Management).</b> The aim is to determine if the drug Roflumilast can be effective in the treatment of obese patients with asthma with poor disease control.&nbsp; The results will soon be published.</p><p>&nbsp;</p><p><b>REACH (Resistant Airway Obstruction in Children). </b>This trial observed airway obstruction in 582 children. The study showed that kids without a history of asthma had a lower post-BD FEV1% predicted (p = 0.008). Those without allergic rhinitis had lower post-BD FEV1% predicted (p = 0.003). On the other hand, children with no history of asthma, and those with asthma but no allergic rhinitis, had lower pulmonary function.</p><p>&nbsp;</p></div></div></div>
</div><div data-element-id="elm_e4mJ5VvL6RVmZ1GQQG2i4A" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_e4mJ5VvL6RVmZ1GQQG2i4A"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><p>COPD is a national concern</p></div></div></h2></div>
<div data-element-id="elm_IqgxMM94Pb5CaOZGWO09rQ" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_IqgxMM94Pb5CaOZGWO09rQ"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><p>According to The National Heart, Lung and Blood Institute (NHLBI), more than 16 million Americans have been diagnosed with COPD, and millions more don’t know they suffer this condition. Furthermore, in 2020, the projected annual costs of patient-related care was $49 billion dollars. That´s is why the American Congress requested the NHLBI help to develop a plan to combat this problem; that´s how the National Action Plan was born.</p><p>&nbsp;</p><p>Even tough, this document was released in 2017, it is continuously updated to make it adequate to the everchanging events and circumstances that are required in the war against COPD.</p></div></div></div></div>
</div><div data-element-id="elm_xfL3aGosz71fw-KmAxT1JQ" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_xfL3aGosz71fw-KmAxT1JQ"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><div style="color:inherit;"><p>The Nation Action Plan states five main goals:</p></div></div></div></h2></div>
<div data-element-id="elm_l1YX0hp1lbxf2i9pMqZoAw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_l1YX0hp1lbxf2i9pMqZoAw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>&nbsp;<span style="color:inherit;">GOAL 1. Empower people with COPD, their families, and caregivers to recognize and reduce the burden of COPD.</span></p><div style="color:inherit;"><p>&nbsp;</p><p>GOAL 2. Improve the prevention, diagnosis, treatment, and management of COPD by </p><p>improving the quality of care delivered across the health care continuum.</p><p>&nbsp;</p><p>GOAL 3. Collect, analyze, report, and disseminate COPD-related public health data that drive change and track progress.</p><p>&nbsp;</p><p>GOAL 4 Increase and sustain research to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD.</p><p>&nbsp;</p><p>GOAL 5. Translate national policy, educational, and program recommendations into </p><p>research and public health care actions.</p><p>&nbsp;</p><p>To combat this terrible disease it is necessary to have a united front. Fortunately, researchers, institutions, health educators, physicians and organizations are making joined and organized efforts that are changing the life quality of patients. We hope that some day COPD will be defeated.</p></div></div></div>
</div></div></div></div></div></div> ]]></content:encoded><pubDate>Sun, 07 Nov 2021 19:21:37 +0000</pubDate></item><item><title><![CDATA[The link between poor lung function and Sudden Cardiac Death]]></title><link>https://www.spiroscoutusa.com/blogs/post/The-link-between-poor-lung-function-and-Sudden-Cardiac-Death</link><description><![CDATA[<img align="left" hspace="5" src="https://www.spiroscoutusa.com/pulmonar1.jpg"/>Scientists have found that there is a close relationship between poor lung function and coronary events, although it is unclear whether lung status is ]]></description><content:encoded><![CDATA[<div class="zpcontent-container blogpost-container "><div data-element-id="elm_YFtwquZlSQuU2s1kles8zw" data-element-type="section" class="zpsection "><style type="text/css"></style><div class="zpcontainer-fluid zpcontainer"><div data-element-id="elm_eHnfvSfWRpm3CPgt9wpQgQ" data-element-type="row" class="zprow zprow-container zpalign-items- zpjustify-content- " data-equal-column=""><style type="text/css"></style><div data-element-id="elm_Km0fdR9jQ1-gl_MSpVIhKQ" data-element-type="column" class="zpelem-col zpcol-12 zpcol-md-12 zpcol-sm-12 zpalign-self- "><style type="text/css"></style><div data-element-id="elm_jCO_8fytSDWfNrHy5i8qSw" data-element-type="text" class="zpelement zpelem-text "><style></style><div class="zptext zptext-align-center " data-editor="true"><div style="color:inherit;"><p style="text-align:left;">Scientists have found that there is a close relationship between poor lung function and coronary events, although it is unclear whether lung status is a predictor of Sudden Cardiac Death.</p></div></div>
</div><div data-element-id="elm_Ywdr-tSQDLyqcHDiBuou2w" data-element-type="image" class="zpelement zpelem-image "><style> [data-element-id="elm_Ywdr-tSQDLyqcHDiBuou2w"].zpelem-image { border-radius:1px; } </style><div data-caption-color="" data-size-tablet="size-original" data-size-mobile="size-original" data-align="center" data-tablet-image-separate="" data-mobile-image-separate="" class="zpimage-container zpimage-align-center zpimage-size-medium zpimage-tablet-fallback-medium zpimage-mobile-fallback-medium hb-lightbox " data-lightbox-options="
                type:fullscreen,
                theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/pulmonar1.jpg" size="medium" data-lightbox="true" style="width:650px;"/></picture></span></figure></div>
</div><div data-element-id="elm_V-0nztJwHigCM7RxcdVe0g" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_V-0nztJwHigCM7RxcdVe0g"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><div style="color:inherit;"><p>For this reason, Suneela Zaigham PhD (Lund University, Lund, Sweden) and her collaborators conducted a study, for about 40 years, among 28,584 middle-aged people, with no history of acute coronary events, living in Malmö, Sweden. They aimed to try to test whether poor lung function could be considered an important risk marker of Sudden Cardiac Death.</p></div></div></div>
</div><div data-element-id="elm_FIu93YZRx8PyygkbQbRKdw" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_FIu93YZRx8PyygkbQbRKdw"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p>Relationship between FEV1 and Sudden Cardiac Death</p></div></h2></div>
<div data-element-id="elm_wBh1yPPlYF1lmwEuwVOx4w" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_wBh1yPPlYF1lmwEuwVOx4w"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div><p style="color:inherit;">While it has long been known that poor lung function can predict a coronary event, it was uncertain if different patterns of lung deterioration had the same ability to predict such events, whether non-fatal or sudden death.</p><p style="color:inherit;">&nbsp;</p><p style="color:inherit;">The study that Suneela Zaigham et al. conducted, considered an analysis that included the adjustment of potential factors. This is what they found:<span style="color:inherit;">&nbsp;</span></p><ul style="color:inherit;"><li>1 standard deviation reduction in FEV<sub>1</sub> was associated with a Hazard Ratio (HR) for Sudden Cardiac Death of 1.23 (95% Confidence Interval (CI) 1.15 - 1.31).</li></ul><ul style="color:inherit;"><li><span style="font-size:7pt;">&nbsp;</span><span style="color:inherit;font-size:7pt;">&nbsp;</span><span style="color:inherit;">However, 1 standard deviation in FEV</span><sub style="color:inherit;">1</sub><span style="color:inherit;"> was associated with a lower (but significant) risk of non-fatal events with a Hazard Ratio (HR) of 1.08 (95% CI, 1.04 – 1.13; P (probability) for equal associations = .002).</span></li><li><span style="color:inherit;">·</span><span style="color:inherit;font-size:7pt;">&nbsp; </span><span style="color:inherit;">The results were the same among participants who had never smoked, with a Hazard Ratio for Sudden Cardiac Death of 1.34 (95% Confidence Interval, 1.15 – 1.55). The HR for non-fatal events was 1.11 (95% CI, 1.02 – 1.21; P (probability) for equal associations =.038).</span>&nbsp;</li></ul><p style="color:inherit;">&nbsp;</p><p style="color:inherit;">Those figures show a higher risk of fatal coronary events than non-fatal ones, even in people whose lung function was slightly below the normal range (but still considered normal). Therefore, this suggests that there exists a relationship between lung health and Sudden Cardiac Death.</p><p style="color:inherit;">&nbsp;</p><p style="color:inherit;">In fact, Dr. Zaigham reported that a low <a href="https://www.schillerus.com/blogs/post/when-are-fev1-and-fvc-maneuvers-acceptable" target="_blank" rel="">FEV</a><sub><a href="https://www.schillerus.com/blogs/post/when-are-fev1-and-fvc-maneuvers-acceptable" target="_blank" rel="">1</a></sub> was indeed associated with both, Sudden Cardiac Death, and non-fatal coronary events; but in addition, a low FEV1 was strongly associated with the prediction of Sudden Cardiac Death.</p><p style="color:inherit;">&nbsp;</p><p><span style="color:inherit;">She also suggests taking advantage of spirometry early in life, as this simple test can go a long way in stratifying the risk of Sudden Cardiac Death. In other words, the use of </span><a href="https://www.schillerus.com/blogs/post/spirometry-an-underestimated-test" style="color:rgb(234, 119, 4);">spirometry</a><span style="color:inherit;"> is a great tool to reduce cardiovascular risks.</span></p><p style="color:inherit;">&nbsp;</p><p><a href="https://portal.research.lu.se/portal/en/publications/low-lung-function-sudden-cardiac-death-and-nonfatal-coronary-events-in-the-general-population%287a2579f2-50c4-484f-a080-2b4846f15c4a%29.html" style="color:rgb(234, 119, 4);">Reference</a></p><p style="color:inherit;">&nbsp;</p><p style="color:inherit;">&nbsp;</p></div>
</div></div></div></div></div></div></div> ]]></content:encoded><pubDate>Thu, 07 Oct 2021 22:05:27 +0000</pubDate></item><item><title><![CDATA[Spirometry is vital for diagnoses and monitoring of Chronic Obstructive Pulmonary Disease (COPD)]]></title><link>https://www.spiroscoutusa.com/blogs/post/Spirometry-for-diagnosis-COPD</link><description><![CDATA[<img align="left" hspace="5" src="https://www.spiroscoutusa.com/green-stethoscope-form-lung-isolated-white-background-3d-render.jpg"/>Spirometry is vital for diagnoses and monitoring of Chronic Obstructive Pulmonary Disease (COPD)]]></description><content:encoded><![CDATA[<div class="zpcontent-container blogpost-container "><div data-element-id="elm_Bkh9_EVnQhu1qVkmCvysVg" data-element-type="section" class="zpsection "><style type="text/css"></style><div class="zpcontainer-fluid zpcontainer"><div data-element-id="elm_oismzV1bSQqGvSFuTRGRcg" data-element-type="row" class="zprow zprow-container zpalign-items- zpjustify-content- " data-equal-column=""><style type="text/css"></style><div data-element-id="elm_vfWxE59pQbSEYWqXqKlAQQ" data-element-type="column" class="zpelem-col zpcol-12 zpcol-md-12 zpcol-sm-12 zpalign-self- "><style type="text/css"></style><div data-element-id="elm_0nIt9gyfRY6w4WETwKdhlA" data-element-type="heading" class="zpelement zpelem-heading "><style></style><h2
 class="zpheading zpheading-align-center " data-editor="true"><div style="color:inherit;"><p><span style="font-size:12pt;">By Claudio López Bruzual M.D.</span></p></div></h2></div>
<div data-element-id="elm_5aeqoPCfRwibmogX3UrKNg" data-element-type="text" class="zpelement zpelem-text "><style></style><div class="zptext zptext-align-center " data-editor="true"><div style="color:inherit;"><p style="text-align:left;"><span style="font-size:12pt;">Chronic Obstructive Pulmonary Disease (COPD)</span><span style="font-size:12pt;">is the seventh leading cause of death globally. Moreover, in 2014 it was estimated that, in the United States, this disease was the fourth cause of mortality with a rate of 39.1 deaths per 100,000 individuals; of them, 44.3 were males and 35.6 females.</span></p></div></div>
</div><div data-element-id="elm_HlNeHBWPcRKBvLrLGzf9aw" data-element-type="image" class="zpelement zpelem-image "><style> [data-element-id="elm_HlNeHBWPcRKBvLrLGzf9aw"].zpelem-image { border-radius:1px; } </style><div data-caption-color="" data-size-tablet="size-original" data-size-mobile="size-original" data-align="center" data-tablet-image-separate="" data-mobile-image-separate="" class="zpimage-container zpimage-align-center zpimage-size-medium zpimage-tablet-fallback-medium zpimage-mobile-fallback-medium hb-lightbox " data-lightbox-options="
                type:fullscreen,
                theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/green-stethoscope-form-lung-isolated-white-background-3d-render.jpg" size="medium" data-lightbox="true" style="width:1500px;padding:0px;margin:0px;"/></picture></span></figure></div>
</div><div data-element-id="elm_k-RQ5KvohbmDqOqAtfMOEQ" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_k-RQ5KvohbmDqOqAtfMOEQ"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p><span style="font-size:12pt;">As you know, the effects of this problem are devastating for patients on a physical, emotional, and economic level. Comorbidities, such as osteoporosis and cardiovascular problems that affect the patient's (and their family's) life, often occur, leading to depression. And on the economic side, it is estimated that the costs, direct and indirect, for the U.S. health system reach 36 billion dollars annually. &nbsp;</span></p><p><span style="font-size:12pt;">This makes it clear that having a good management of this disease results in an enormous improvement in the well-being of patients, the hospital system, society and for you, as a health professional. Unfortunately, one of the most useful and effective tools to achieve this is often undervalued, and therefore underused: </span><a href="https://www.schillerus.com/blogs/post/risks-of-underestimating-chronic-obstructive-pulmonary-disease-in-primary-care"><span style="font-size:12pt;">spirometry</span></a><span style="font-size:12pt;">.</span></p></div></div>
</div><div data-element-id="elm_c8oElzlXx1XfsSis7GlarQ" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_c8oElzlXx1XfsSis7GlarQ"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p><span style="font-size:32px;">Advantages of spirometry in the treatment of COPD</span></p></div></h2></div>
<div data-element-id="elm_ZTWtu8z8zyk4UJcdmSW3bw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_ZTWtu8z8zyk4UJcdmSW3bw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p><span style="font-size:12pt;">The Global Initiative for Chronic Obstructive Lung Disease (GOLD), in its 2020 report, emphasizes how important it is that the first contact physician to be able to detect the disease to immediately refer the patient, so the specialist can provide appropriate treatment and management of COPD on time.</span></p><p><span style="font-size:12pt;">As you know, individuals who require spirometry for diagnosis/evaluation of their pulmonary function are as follows:</span></p><ul><li><b><span style="font-size:12pt;">Patients with recurrent respiratory events. </span></b><span style="font-size:12pt;">For example, acute bronchitis, undertreated flu, chronic coughs, or people with excessive sputum production.</span></li><li><b style="color:inherit;"><span style="font-size:12pt;">Patients with a history of exposure to risk factors. </span></b><span style="color:inherit;font-size:12pt;">That is, smokers, former smokers, passive smokers, patients with alpha-1-antitrypsin deficiency and occupational exposure</span><span style="color:inherit;font-size:12pt;">to</span><span style="color:inherit;font-size:12pt;">dust, vapors, organic and chemical materials.</span></li><li><b style="color:inherit;"><span style="font-size:12pt;">Subjects with limited physical activity due to dyspnea.</span></b></li><li><b style="color:inherit;"><span style="font-size:12pt;">People with a family history of COPD.</span></b></li></ul><p><span style="font-size:12pt;">The fact that the first contact physician indicates routine spirometry or, as the case may be, body plethysmography, speeds up diagnosis, which is vital in the long term for assessing response to treatment, medication adjustment, and monitoring disease progression.</span></p><p><span style="font-size:12pt;">A relationship between </span><a href="https://www.schillerus.com/blogs/post/when-are-fev1-and-fvc-maneuvers-acceptable"><span style="font-size:12pt;">FEV<sub>1</sub>/FVC</span></a><sub></sub><span style="font-size:12pt;">performed 15 minutes after inhalation of a Short-Acting Beta-Agonist SABA bronchodilator (salbutamol, albuterol)</span><span style="font-size:12pt;">&lt;</span><span style="font-size:12pt;">0.70 confirms the existence of a persistent or fixed limitation to airflow. And this can only be known with certainty by spirometry.</span></p></div></div>
</div><div data-element-id="elm_-52ACdFavCvvO71K059FXQ" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_-52ACdFavCvvO71K059FXQ"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-center " data-editor="true"><div style="color:inherit;"><p><span style="font-size:32px;">The ravages of late COPD diagnosis</span></p></div></h2></div>
<div data-element-id="elm_2d70OWIu8-jSfNY6Hk1pRw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_2d70OWIu8-jSfNY6Hk1pRw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p><span style="font-size:12pt;">Despite the recommendations of various international organizations, spirometry remains underutilized in primary clinical practice. In general, its limited use is attributed, on the patient’s side, to ignorance about the benefit of the early diagnoses of the disease, to lack of time and/or resources. Or to the lack of familiarity with the technique and interpretation process on the side of the primary care physicians.</span></p><p><span style="font-size:12pt;">Although patients may be referred to the specialist for diagnosis, follow-up in those circumstances will always be limited due to late detection. By the time </span><a href="https://www.schillerus.com/blogs/post/endotypical-COPD-treatment"><span style="font-size:12pt;">COPD</span></a><span style="font-size:12pt;"> is diagnosed, the patient has already gone through incorrect treatments or has already lost valuable time that may have improved the prognosis and management of the disease.</span></p><p><span style="font-size:12pt;">Reference: </span><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886101/"><span style="font-size:12pt;">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886101/</span></a></p></div></div>
</div></div></div></div></div></div> ]]></content:encoded><pubDate>Sun, 26 Sep 2021 19:29:34 +0000</pubDate></item><item><title><![CDATA[Tips for buying a spirometer This is what you should know before buying a spirometer ]]></title><link>https://www.spiroscoutusa.com/blogs/post/Tips-for-buying-a-spirometer</link><description><![CDATA[<img align="left" hspace="5" src="https://www.spiroscoutusa.com/3d-illustration-human-body-with-lung-pain.jpg"/>The havocs of coronavirus have made reliable and accurate spirometry more necessary than ever to carefully follow-up recovered COVID-19 patients.]]></description><content:encoded><![CDATA[<div class="zpcontent-container blogpost-container "><div data-element-id="elm_8cq-ot2UQkWdFRJf-uiDrg" data-element-type="section" class="zpsection "><style type="text/css"></style><div class="zpcontainer-fluid zpcontainer"><div data-element-id="elm_husxK7iuSx-kyVLw4qiCyQ" data-element-type="row" class="zprow zprow-container zpalign-items- zpjustify-content- " data-equal-column=""><style type="text/css"></style><div data-element-id="elm_hDpT09j7ToyvHWwt-Fbf6Q" data-element-type="column" class="zpelem-col zpcol-12 zpcol-md-12 zpcol-sm-12 zpalign-self- "><style type="text/css"></style><div data-element-id="elm_4RzUWxI-CiH73H9XEE067g" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_4RzUWxI-CiH73H9XEE067g"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><div><div><div><p>The havocs of coronavirus have made reliable and accurate spirometry more necessary than ever to carefully follow-up recovered COVID-19 patients.&nbsp;</p><div><br></div></div></div></div><div></div></div></div>
</div><div data-element-id="elm_9U26KtDoWZSIHmZpeYKwfQ" data-element-type="image" class="zpelement zpelem-image "><style> [data-element-id="elm_9U26KtDoWZSIHmZpeYKwfQ"].zpelem-image { border-radius:1px; } </style><div data-caption-color="" data-size-tablet="size-original" data-size-mobile="size-original" data-align="center" data-tablet-image-separate="" data-mobile-image-separate="" class="zpimage-container zpimage-align-center zpimage-size-medium zpimage-tablet-fallback-medium zpimage-mobile-fallback-medium hb-lightbox " data-lightbox-options="
                type:fullscreen,
                theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/3d-illustration-human-body-with-lung-pain.jpg" size="medium" data-lightbox="true" style="width:1500px;"/></picture></span></figure></div>
</div><div data-element-id="elm_8yHnSSVyWhJ456fHM4mqcQ" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_8yHnSSVyWhJ456fHM4mqcQ"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>The growing demand for pulmonary function testing due to the COVID-19 pandemic has lead many physicians to consider renewing their spirometers or acquiring more units. And even doctors who previously did not offer this test are deciding to get spirometers to provide better care to their patients from the first appointment.&nbsp;</p><p>Whatever your reasons for buying equipment, here are some practical tips to help you make the best decision.</p></div></div>
</div><div data-element-id="elm_0-9Lad59jFqGUA99A7oNLQ" data-element-type="imagetext" class="zpelement zpelem-imagetext "><style> [data-element-id="elm_0-9Lad59jFqGUA99A7oNLQ"].zpelem-imagetext{ border-radius:1px; } </style><div data-size-tablet="size-original" data-size-mobile="size-original" data-align="left" data-tablet-image-separate="" data-mobile-image-separate="" class="zpimagetext-container zpimage-with-text-container zpimage-align-left zpimage-size-medium zpimage-tablet-fallback-medium zpimage-mobile-fallback-medium hb-lightbox " data-lightbox-options="
            type:fullscreen,
            theme:dark"><figure role="none" class="zpimage-data-ref"><span class="zpimage-anchor" role="link" tabindex="0" aria-label="Open Lightbox" style="cursor:pointer;"><picture><img class="zpimage zpimage-style-none zpimage-space-none " src="/espirocout%20bn.jpg" size="medium" data-lightbox="true" style="width:1000px;"/></picture></span></figure><div class="zpimage-text zpimage-text-align-left " data-editor="true"><div style="color:inherit;"><p><span style="font-size:28px;">Tips to buy a good spirometer</span></p><div style="color:inherit;"><div><ul><li><b>Don't make the decision based upon price.&nbsp;</b>Make an investment, not an expense. The lower the cost of the equipment, the lower the performance and accuracy it will provide, what is the point of using something that will force you to repeat the test several times? The time you will waste repeating the test and using disposable mouthpieces and filters will eventually raise the low initial cost considerably.&nbsp; Simply put, cheap costs dearly.</li><li><b>What kind of patients do you attend?&nbsp;</b>If besides adults you attend seniors, and children, you need a device that will make it easier for you to perform the test on all of them. Children and the elderly must be taken particularly into account because, due to their age, they may not be able to seal tight their lips around the mouthpiece. So, it is convenient that the mouthpiece of the spirometer adapts comfortably to their mouth.&nbsp;</li><li><b>Make sure that it offers you various measurement programs.&nbsp;</b>The ATS (American Thoracic Society) requires that at least the three best attempts should be printed, in addition to the FV and VT curves; not all devices have this capability. Besides, the device must also provide the values FEV1, FVC (or FEV6), FEV1 / FVC, FET (Forced Expiratory Time) and the number of attempts. If it can also calculate the variance between FEV1 and FVC, much better.</li><li><b>Choose a device that complies the standards.</b>&nbsp; This will make your job much easier to determine the validity of the test; decide on a spirometer that is OSHA/ATS/ERS compliant.&nbsp;</li><li><b>Prefer spirometers that are calibration-free.&nbsp;</b>This type of device will save you time because it will always be ready to work on demand. Have we mentioned that this will also save you a lot of time?</li><li><b>Choose a safe device for you and your patients.&nbsp;</b>&nbsp;With the COVID-19 pandemic, hygiene is more important than ever, so it is convenient to acquire a spirometer that is cross-contamination free. Also, consider whether the operation of the equipment allows you to maintain a safe distance from the patient.&nbsp;</li><li><b><span style="font-size:12pt;"><span style="font-size:14px;">Customer service is very important.</span>&nbsp;</span></b><span>Make sure that the company selling the device has a good pre-sales service: Do they solve all your doubts? Do they offer you free training to use the device? Do they offer free demos to see the spirometer in action? Post-sales service is also another important point: does the company provide disposable filters and mouthpieces? Do software updates have extra cost? Do they provide maintenance and spare parts?<br><br></span></li></ul></div><div><div><div><p style="margin-left:18pt;">As you may have already noticed, it is a question of acquiring a spirometer of good quality. Not only will it benefit your patients by offering them reliable and accurate tests, but in the long run the investment will be worth it because you will be able to use the device for many years to come.</p></div></div></div></div></div></div>
</div></div><div data-element-id="elm_G1PSPUBA0t_eE9Af19vIcA" data-element-type="heading" class="zpelement zpelem-heading "><style> [data-element-id="elm_G1PSPUBA0t_eE9Af19vIcA"].zpelem-heading { border-radius:1px; } </style><h2
 class="zpheading zpheading-style-none zpheading-align-left " data-editor="true"><div style="color:inherit;"><div><h2 style="font-size:32px;"><div><p>SpiroScout, ultrasonic spirometry</p></div></h2></div><div><div></div></div></div></h2></div>
<div data-element-id="elm_7W2i4pWSQNyee7dnD18Ucw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_7W2i4pWSQNyee7dnD18Ucw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><p>In Schiller, we have SpiroScout an ultrasonic spirometer that covers the points mentioned above. One of its big strengths in times of pandemic is that it avoids cross-contamination because:<br><br></p><ul><li>It uses our unique ScoutTube mouthpiece, which isolates the patient's exhalation and avoids contact with the device´s sensors.</li><li>The device can also use a high-efficiency PFT filter, which is a must nowadays.</li><li>The health care professional can perform the test while maintaining the distance recommended by CDC (Centers for Disease Control and Prevention)</li></ul></div></div>
</div><div data-element-id="elm_eCbW8UA1Sc5iOHbRAkJ1Dw" data-element-type="text" class="zpelement zpelem-text "><style> [data-element-id="elm_eCbW8UA1Sc5iOHbRAkJ1Dw"].zpelem-text { border-radius:1px; } </style><div class="zptext zptext-align-left " data-editor="true"><div style="color:inherit;"><div><p>To learn more about SpiroScout, <span style="text-decoration-line:underline;"><a href="https://workdrive.zohoexternal.com/external/1PUK3azM29Y-KJ6D8" title="download this&nbsp;sheet" target="_blank" rel="">download this&nbsp;</a><a href="https://workdrive.zohoexternal.com/external/1PUK3azM29Y-KJ6D8" title="download this&nbsp;sheet" target="_blank" rel="">sheet</a>.&nbsp;</span></p></div><div style="margin-bottom:20px;"></div></div></div>
</div></div></div></div></div></div> ]]></content:encoded><pubDate>Thu, 02 Sep 2021 17:19:06 +0000</pubDate></item></channel></rss>